Boris Bleijlevens

2.7k total citations · 1 hit paper
40 papers, 2.0k citations indexed

About

Boris Bleijlevens is a scholar working on Molecular Biology, Renewable Energy, Sustainability and the Environment and Oncology. According to data from OpenAlex, Boris Bleijlevens has authored 40 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Renewable Energy, Sustainability and the Environment and 6 papers in Oncology. Recurrent topics in Boris Bleijlevens's work include Metalloenzymes and iron-sulfur proteins (11 papers), Lysosomal Storage Disorders Research (6 papers) and Electrocatalysts for Energy Conversion (5 papers). Boris Bleijlevens is often cited by papers focused on Metalloenzymes and iron-sulfur proteins (11 papers), Lysosomal Storage Disorders Research (6 papers) and Electrocatalysts for Energy Conversion (5 papers). Boris Bleijlevens collaborates with scholars based in Netherlands, Germany and United Kingdom. Boris Bleijlevens's co-authors include Simon P. J. Albracht, Mohammad Mahdi Jaghoori, Sílvia D. Olabarriaga, Bärbel Friedrich, Coert J. Zuurbier, Ruben Coronel, Antonius Baartscheer, Anneke Koeman, Johannes M. F. G. Aerts and Nina C. Weber and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Boris Bleijlevens

37 papers receiving 2.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation

2017 466 citations Laween Uthman, Antonius Baartscheer et al. Diabetologia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Boris Bleijlevens Netherlands	21	847	467	415	368	277	40	2.0k
Nathalie Rugani France	13	1.3k 1.6×	48 0.1×	115 0.3×	113 0.3×	211 0.8×	21	1.8k
Yue Xi China	14	741 0.9×	136 0.3×	32 0.1×	91 0.2×	205 0.7×	30	2.0k
Xin Cao China	25	992 1.2×	75 0.2×	37 0.1×	87 0.2×	75 0.3×	175	2.4k
Thomas J. Bronzert United States	12	1.0k 1.2×	25 0.1×	464 1.1×	121 0.3×	393 1.4×	13	1.9k
Cuiping Liu China	28	1.3k 1.5×	60 0.1×	95 0.2×	145 0.4×	135 0.5×	142	2.7k
Fatima Mraiche Qatar	22	603 0.7×	42 0.1×	78 0.2×	59 0.2×	145 0.5×	60	1.3k
Luis Alfonso Martínez‐Cruz Spain	27	1.1k 1.3×	26 0.1×	73 0.2×	138 0.4×	72 0.3×	67	2.0k
Qicai Liu China	28	1.5k 1.8×	23 0.0×	62 0.1×	249 0.7×	296 1.1×	134	2.7k
Hanchun Chen China	29	1.4k 1.6×	43 0.1×	53 0.1×	101 0.3×	88 0.3×	102	2.6k
Renshuai Zhang China	23	1.0k 1.2×	28 0.1×	68 0.2×	67 0.2×	115 0.4×	84	1.9k

Countries citing papers authored by Boris Bleijlevens

Since Specialization

Citations

This map shows the geographic impact of Boris Bleijlevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Bleijlevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Bleijlevens more than expected).

Fields of papers citing papers by Boris Bleijlevens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Bleijlevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Bleijlevens. The network helps show where Boris Bleijlevens may publish in the future.

Co-authorship network of co-authors of Boris Bleijlevens

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Bleijlevens. A scholar is included among the top collaborators of Boris Bleijlevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Bleijlevens. Boris Bleijlevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Remst, Dennis F.G., Anne K. Wouters, Maaike E. Ressing, et al.. (2025). Increasing the odds: antibody-mediated delivery of two distinct immunogenic T-cell epitopes with one antibody. OncoImmunology. 14(1). 2508050–2508050.

Meijden, Els van der, Alexandra M. Terry, Dennis Verzijl, et al.. (2025). Characterization of antibody Fc:Fc interactions by a VHH blocking technology. Immunobiology. 230(4). 152936–152936.

Remst, Dennis F.G., Michel G.D. Kester, Renate S. Hagedoorn, et al.. (2023). Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8+ T-cell immunity towards cancer cells. Cancer Gene Therapy. 31(1). 58–68. 4 indexed citations

Gram, Anna M., Boris Bleijlevens, Renate S. Hagedoorn, et al.. (2023). Comparison of methods generating antibody-epitope conjugates for targeting cancer with virus-specific T cells. Frontiers in Immunology. 14. 1183914–1183914. 6 indexed citations

Bdira, Fredj Ben, Wouter W. Kallemeijn, Saskia Scheij, et al.. (2017). Stabilization of Glucocerebrosidase by Active Site Occupancy. ACS Chemical Biology. 12(7). 1830–1841. 21 indexed citations

Sorrentino, Vincenzo, Marit B. de Wissel, Marlene van den Berg, et al.. (2017). LRSAM1-mediated ubiquitylation is disrupted in axonal Charcot–Marie–Tooth disease 2P. Human Molecular Genetics. 26(11). 2034–2041. 11 indexed citations

Uthman, Laween, Antonius Baartscheer, Boris Bleijlevens, et al.. (2017). Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation. Diabetologia. 61(3). 722–726. 466 indexed citations breakdown →

Jaghoori, Mohammad Mahdi, Boris Bleijlevens, & Sílvia D. Olabarriaga. (2016). 1001 Ways to run AutoDock Vina for virtual screening. Journal of Computer-Aided Molecular Design. 30(3). 237–249. 141 indexed citations

Sorrentino, Vincenzo, et al.. (2011). Distinct Functional Domains Contribute to Degradation of the Low Density Lipoprotein Receptor (LDLR) by the E3 Ubiquitin Ligase Inducible Degrader of the LDLR (IDOL). Journal of Biological Chemistry. 286(34). 30190–30199. 43 indexed citations

10.

Witte, Martin D., Wouter W. Kallemeijn, Jan Aten, et al.. (2010). Ultrasensitive in situ visualization of active glucocerebrosidase molecules. Nature Chemical Biology. 6(12). 907–913. 194 indexed citations

11.

Bleijlevens, Boris, et al.. (2007). Replacement of non-heme Fe(II) with Cu(II) in the α-ketoglutarate dependent DNA repair enzyme AlkB: Spectroscopic characterization of the active site. Journal of Inorganic Biochemistry. 101(7). 1043–1048. 15 indexed citations

12.

Bleijlevens, Boris, Mariëlle J. van Breemen, Wilma E. Donker‐Koopman, Chris G. de Koster, & Johannes M. F. G. Aerts. (2007). Detection of mutant protein in complex biological samples: Glucocerebrosidase mutations in Gaucher’s disease. Analytical Biochemistry. 372(1). 52–61. 4 indexed citations

13.

Long, Minnan, Jingjing Liu, Zhifeng Chen, et al.. (2006). Characterization of a HoxEFUYH type of [NiFe] hydrogenase from Allochromatium vinosum and some EPR and IR properties of the hydrogenase module. JBIC Journal of Biological Inorganic Chemistry. 12(1). 62–78. 34 indexed citations

14.

Bleijlevens, Boris, Zhujun Chen, Tianshu Li, et al.. (2006). Characterization of a cyanobacterial-like uptake [NiFe] hydrogenase: EPR and FTIR spectroscopic studies of the enzyme from Acidithiobacillus ferrooxidans. JBIC Journal of Biological Inorganic Chemistry. 12(2). 212–233. 27 indexed citations

15.

Bleijlevens, Boris, Thorsten Buhrke, Eddy van der Linden, Bärbel Friedrich, & Simon P. J. Albracht. (2004). The Auxiliary Protein HypX Provides Oxygen Tolerance to the Soluble [NiFe]-Hydrogenase of Ralstonia eutropha H16 by Way of a Cyanide Ligand to Nickel. Journal of Biological Chemistry. 279(45). 46686–46691. 59 indexed citations

16.

Linden, Eddy van der, Bart W. Faber, Boris Bleijlevens, et al.. (2004). Selective release and function of one of the two FMN groups in the cytoplasmic NAD⁺‐reducing [NiFe]‐hydrogenase from Ralstonia eutropha. European Journal of Biochemistry. 271(4). 801–808. 42 indexed citations

17.

Linden, Eddy van der, Tanja Burgdorf, Michael Bernhard, et al.. (2004). The soluble [NiFe]-hydrogenase from Ralstonia eutropha contains four cyanides in its active site, one of which is responsible for the insensitivity towards oxygen. JBIC Journal of Biological Inorganic Chemistry. 9(5). 616–626. 54 indexed citations

18.

Bleijlevens, Boris. (2002). Activation and sensing of hydrogen in nature. UvA-DARE (University of Amsterdam). 5 indexed citations

19.

Buhrke, Thorsten, et al.. (2001). Involvement of hyp gene products in maturation of the H2-sensing [NiFe] hydrogenase of Ralstonia eutropha.. Journal of Biological Chemistry. 183. 7087–7093. 3 indexed citations

20.

Bleijlevens, Boris, Bart W. Faber, & Simon P. J. Albracht. (2001). The [NiFe] hydrogenase from Allochromatium vinosum studied in EPR-detectable states: H/D exchange experiments that yield new information about the structure of the active site. JBIC Journal of Biological Inorganic Chemistry. 6(8). 763–769. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact